Andrew Hirsch
CEO of C4 Therapeutics
Contact
- Social accounts: linkedin
Companies
Company
Roles
C4 Therapeutics
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
CEO
Editas Medicine
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.
Board Member